An extension study for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development (Study 208).
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2015
At a glance
- Drugs Retigabine (Primary)
- Indications Generalised epilepsy; Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2015 New trial record